senate Bill S2722

2017-2018 Legislative Session

Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Rules Committee


  • Introduced
  • In Committee
  • On Floor Calendar
    • Passed Senate
    • Passed Assembly
  • Delivered to Governor
  • Signed/Vetoed by Governor

Your Voice

do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

view actions (14)
Assembly Actions - Lowercase
Senate Actions - UPPERCASE
Jun 20, 2018 committed to rules
Jun 05, 2018 advanced to third reading
Jun 04, 2018 2nd report cal.
May 31, 2018 1st report cal.1486
Jan 03, 2018 referred to health
returned to senate
died in assembly
Apr 24, 2017 referred to health
delivered to assembly
passed senate
Mar 13, 2017 advanced to third reading
Mar 08, 2017 2nd report cal.
Mar 07, 2017 1st report cal.387
Jan 17, 2017 referred to health

Votes

view votes

May 31, 2018 - Health committee Vote

S2722
17
0
committee
17
Aye
0
Nay
0
Aye with Reservations
0
Absent
0
Excused
0
Abstained
show Health committee vote details

Mar 7, 2017 - Health committee Vote

S2722
16
0
committee
16
Aye
0
Nay
0
Aye with Reservations
0
Absent
1
Excused
0
Abstained
show Health committee vote details

Co-Sponsors

view additional co-sponsors

S2722 (ACTIVE) - Details

See Assembly Version of this Bill:
A2970
Current Committee:
Senate Rules
Law Section:
Public Health Law
Laws Affected:
Amd §3302, add §3306-a, Pub Health L; amd §220.00, Pen L
Versions Introduced in 2019-2020 Legislative Session:
S1652, A6757

S2722 (ACTIVE) - Summary

Provides that a controlled substance analogue shall be deemed to be the controlled substance to which it is substantially similar or mimics.

S2722 (ACTIVE) - Sponsor Memo

S2722 (ACTIVE) - Bill Text download pdf


                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  2722

                       2017-2018 Regular Sessions

                            I N  S E N A T E

                            January 17, 2017
                               ___________

Introduced  by  Sens. KLEIN, AMEDORE, GALLIVAN, KENNEDY, MURPHY, O'MARA,
  ORTT, SERINO, VALESKY -- read twice  and  ordered  printed,  and  when
  printed to be committed to the Committee on Health

AN  ACT to amend the public health law and the penal law, in relation to
  controlled substance analogues

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1.  Section 3302 of the public health law is amended by adding
a new subdivision 44 to read as follows:
  44.  "CONTROLLED SUBSTANCE ANALOGUE" (A) MEANS A SUBSTANCE, THE CHEMI-
CAL STRUCTURE OF WHICH IS SUBSTANTIALLY SIMILAR TO THE  CHEMICAL  STRUC-
TURE  OF  A  CONTROLLED  SUBSTANCE LISTED IN SCHEDULE I OR II OF SECTION
THIRTY-THREE HUNDRED SIX OF THIS TITLE, AND WHICH EITHER:
  (I) HAS A  STIMULANT,  DEPRESSANT  OR  HALLUCINOGENIC  EFFECT  ON  THE
CENTRAL  NERVOUS SYSTEM THAT MIMICS OR IS SIMILAR TO OR GREATER THAN THE
STIMULANT, DEPRESSANT OR HALLUCINOGENIC EFFECT ON  THE  CENTRAL  NERVOUS
SYSTEM  OF  A CONTROLLED SUBSTANCE LISTED IN SCHEDULE I OR II OF SECTION
THIRTY-THREE HUNDRED SIX OF THIS TITLE; OR
  (II) WITH RESPECT TO A PARTICULAR PERSON, IS  A  SUBSTANCE  THAT  SUCH
PERSON REPRESENTS OR INTENDS TO HAVE A STIMULANT, DEPRESSANT OR HALLUCI-
NOGENIC EFFECT ON THE CENTRAL NERVOUS SYSTEM THAT IS SUBSTANTIALLY SIMI-
LAR  TO  OR  GREATER  THAN  THE  STIMULANT, DEPRESSANT OR HALLUCINOGENIC
EFFECT ON THE CENTRAL NERVOUS SYSTEM OF A CONTROLLED SUBSTANCE LISTED IN
SCHEDULE I OR II OF SECTION THIRTY-THREE HUNDRED SIX OF THIS TITLE.
  (B) SUCH TERM SHALL NOT INCLUDE:
  (I) A CONTROLLED SUBSTANCE;
  (II) ANY SUBSTANCE FOR WHICH THERE IS AN APPROVED NEW DRUG APPLICATION
BY THE FEDERAL FOOD AND DRUG ADMINISTRATION (FDA); OR
  (III) WITH RESPECT TO  A  PARTICULAR  PERSON,  ANY  SUBSTANCE,  IF  AN
EXEMPTION  IS  IN  EFFECT  FOR  INVESTIGATIONAL  USE FOR THAT PERSON, AS

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD07432-01-7

Comments

Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.

By contributing or voting you agree to the Terms of Participation and verify you are over 13.